Aurora Health

moodpath.de →

-94%

est. 2Y upside i

Healthcare

Stage: exit. Country: Germany

Rank

#4361

Sector

Digital Health

Est. Liquidity

~5Y

Data Quality

Data: Medium

The equity opportunity for Aurora Health is extremely risky.

Last updated: March 10, 2026

Bull (5%)+100%

Moodpath unexpectedly thrives as a key component of Schoen Clinic's digital mental health strategy, significantly expanding its user base and revenue to over $10M within two years. This leads to an increased internal valuation of the Moodpath product line to $20M, potentially contributing to a modest upside in Schoen Clinic Group's overall equity value.

Base (25%)0%

Moodpath continues to operate as a supplementary digital offering within Schoen Clinic, maintaining its current revenue level of ~$2M and achieving modest growth to $3-4M within two years. Its strategic importance within the large Schoen Clinic Group (over €1B revenue) does not significantly increase, resulting in no material change to its internal valuation of $10M and negligible impact on Schoen Clinic's equity.

Bear (70%)-90%

The Moodpath product stagnates, is de-emphasized, or fully integrated/rebranded under Schoen Clinic's existing MindDoc platform, failing to generate significant independent revenue or strategic value. Its internal valuation drops to a nominal $1M, leading to a near-total loss of value for any equity hypothetically tied to the Moodpath product line.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Aurora Health was acquired, making its prior preference stack irrelevant. For the parent Schoen Clinic Group, approximately $1B in funding has been raised, which, against a hypothetical valuation of ~$1.1B (based on 2022 revenue of €1.01B), indicates a severe preference stack where investors hold a significant claim ahead of common equity.

Dilution Risk

high

For Aurora Health as an independent entity, dilution risk is moot due to its acquisition. For Schoen Clinic Group, significant prior funding suggests potential for high dilution for common shareholders in future rounds or exits below a very high valuation.

Secondary Liquidity

none

There is no secondary market for equity in the closed Aurora Health. As a private company, Schoen Clinic Group does not have active secondary markets for its shares.

Questions to Ask at the Interview

Strategic questions based on Aurora Health's data — designed to show you've done your homework.

1
“Given Aurora Health's acquisition and 'Closed' status, what is the exact nature of the equity being offered, and how is its value tied to Moodpath's performance or the broader Schoen Clinic Group?”
2
“How does Schoen Clinic plan to differentiate and grow Moodpath within its existing digital health offerings, particularly alongside MindDoc, and what are the specific revenue and user growth targets for Moodpath over the next 2-3 years?”
3
“Considering Schoen Clinic Group's significant funding, how does the company manage liquidation preferences, and what is the expected timeline and mechanism for employee liquidity, especially for those whose equity is tied to a specific product line like Moodpath?”

Community

Valuation Sentiment

Our model estimates -94% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.